| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS:COWZ) is “a factor-based ETF that screens for the 100 highest free cash flow yielding companies in the S&P.” The two biggest sectors are energy and healthcare, Talkington mentioned. “It has a free cash flow yield of 12.5%, a PE of 6.5% and a dividend of 2.5%,” she added.
Shannon Saccocia of Boston Private said Quest Diagnostics Inc. (NYSE:DGX) has 4% to 5% revenue growth and 7% to 9% EPS growth and is a defensive play.
Check out other stocks making moves in the premarket.
Rob Sechan of New Edge Capital Group mentioned that Eli Lilly And Co’s (NYSE:LLY) Alzheimer’s drug “is great too.”
Also Read: Is Tesla Making A Mistake Building Optimus To Resemble A Human? Ark Analyst And Elon Musk Weigh In
Stephen Weiss of Short Hills Capital Partners said that although EQT Corporation (NYSE:EQT) had declined last week, “I think they’ll come back to natgas stocks.”
Joseph Terranova of Virtus Investment Partners chose Northrop Grumman Corporation (NYSE:NOC) as his final trade.
